Search

Your search keyword '"Tzavara V"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Tzavara V" Remove constraint Author: "Tzavara V"
40 results on '"Tzavara V"'

Search Results

1. Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial

2. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

3. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial (Nature Medicine, (2021), 27, 10, (1752-1760), 10.1038/s41591-021-01499-z)

6. Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort

7. Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort

9. Evidence for non-adaptive immune response in HIV infection

10. LEVELS OF THE CIRCULATING CELL-ADHESION MOLECULE E-SELECTIN AND DISEASE PROGRESSION IN HIV-INFECTION

14. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic

15. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

16. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

17. Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial.

18. Clinical Phenotyping for Prognosis and Immunotherapy Guidance in Bacterial Sepsis and COVID-19.

19. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.

20. Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.

21. HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL.

22. Long-term outcomes, residual symptoms and quality of life in COVID-19 hospitalized patients: A 12-month longitudinal study.

23. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein.

24. Case report: The devil was hidden in the mastocytes - an unusually fulminant case of indolent systemic mastocytosis in a 45-year-old patient, missed for almost 20 years.

25. Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.

26. Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.

27. Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasone.

28. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

29. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

30. Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study.

31. Cardiac tamponade in a patient with autoimmune polyglandular syndrome type 2.

32. Pyomyositis and septic hip arthritis due to bacteroides fragilis. A case report.

33. Serum leptin levels in patients undergoing carotid endarterectomy: a pilot study.

34. Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers.

35. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens.

36. Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.

38. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.

39. Facial heliotrope rash as the initial manifestation of acute myelomonocytic leukemia.

40. Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection.

Catalog

Books, media, physical & digital resources